In vitro activities of amphotericin B and AmBisome against Aspergillus isolates recovered from Italian patients treated for haematological malignancies

Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

Thomas J. Walsh, Elias Anaissie, David W. Denning et al. · Clinical Infectious Diseases · 2008 · 2.7K citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Species identification of Aspergillus, Fusarium and Mucorales with direct surface analysis by matrix-assisted laser desorption ionization time-of-flight mass spectrometry

Elena De Carolis, Brunella Posteraro, Cornelia Lass‐Flörl et al. · Clinical Microbiology and Infection · 2011 · 270 citations · Full text

Life Sciences, Biology, Microbiology +14

<i>Aspergillus</i> Section <i>Fumigati</i> : Antifungal Susceptibility Patterns and Sequence-Based Identification

Laura Alcázar‐Fuoli, Emilia Mellado, Ana Alastruey‐Izquierdo et al. · Antimicrobial Agents and Chemotherapy · 2008 · 255 citations · Full text

Life Sciences, Biology, Microbiology +15

In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis

Cornelia Lass‐Flörl, G Kofler, Gabriele Kropshofer et al. · Journal of Antimicrobial Chemotherapy · 1998 · 221 citations

Life Sciences, Infectious Diseases, Microbiology +17

Activities of Antifungal Agents against Yeasts and Filamentous Fungi: Assessment according to the Methodology of the European Committee on Antimicrobial Susceptibility Testing

Cornelia Lass‐Flörl, Astrid Mayr, Susanne Perkhofer et al. · Antimicrobial Agents and Chemotherapy · 2008 · 150 citations · Full text

Life Sciences, Microbiology, Pharmacology +17